These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 29772420)

  • 1. The search for biomarkers of hepatocellular carcinoma and the impact on patient outcome.
    Black AP; Mehta AS
    Curr Opin Pharmacol; 2018 Aug; 41():74-78. PubMed ID: 29772420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biomarkers for the early diagnosis of hepatocellular carcinoma.
    Tsuchiya N; Sawada Y; Endo I; Saito K; Uemura Y; Nakatsura T
    World J Gastroenterol; 2015 Oct; 21(37):10573-83. PubMed ID: 26457017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biomarkers for the Early Detection of Hepatocellular Carcinoma.
    Parikh ND; Mehta AS; Singal AG; Block T; Marrero JA; Lok AS
    Cancer Epidemiol Biomarkers Prev; 2020 Dec; 29(12):2495-2503. PubMed ID: 32238405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer biomarkers for hepatocellular carcinomas: from traditional markers to recent topics.
    Masuda T; Miyoshi E
    Clin Chem Lab Med; 2011 Jun; 49(6):959-66. PubMed ID: 21428856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel biomarkers in hepatocellular carcinoma.
    De Stefano F; Chacon E; Turcios L; Marti F; Gedaly R
    Dig Liver Dis; 2018 Nov; 50(11):1115-1123. PubMed ID: 30217732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biomarkers for Hepatocellular Carcinoma (HCC): An Update.
    Li D; Satomura S
    Adv Exp Med Biol; 2015; 867():179-93. PubMed ID: 26530367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current Practice of Hepatocellular Carcinoma Surveillance.
    Loho IM; Siregar L; Waspodo AS; Hasan I
    Acta Med Indones; 2018 Oct; 50(4):353-360. PubMed ID: 30631003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteomic and metabonomic biomarkers for hepatocellular carcinoma: a comprehensive review.
    Kimhofer T; Fye H; Taylor-Robinson S; Thursz M; Holmes E
    Br J Cancer; 2015 Mar; 112(7):1141-56. PubMed ID: 25826224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum anti-Ku86 is a potential biomarker for early detection of hepatitis C virus-related hepatocellular carcinoma.
    Nomura F; Sogawa K; Noda K; Seimiya M; Matsushita K; Miura T; Tomonaga T; Yoshitomi H; Imazeki F; Takizawa H; Mogushi K; Miyazaki M; Yokosuka O
    Biochem Biophys Res Commun; 2012 May; 421(4):837-43. PubMed ID: 22554520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A structured proteomic approach identifies 14-3-3Sigma as a novel and reliable protein biomarker in panel based differential diagnostics of liver tumors.
    Reis H; Pütter C; Megger DA; Bracht T; Weber F; Hoffmann AC; Bertram S; Wohlschläger J; Hagemann S; Eisenacher M; Scherag A; Schlaak JF; Canbay A; Meyer HE; Sitek B; Baba HA
    Biochim Biophys Acta; 2015 Jun; 1854(6):641-50. PubMed ID: 25448011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatocellular carcinoma surveillance: An evidence-based approach.
    Harris PS; Hansen RM; Gray ME; Massoud OI; McGuire BM; Shoreibah MG
    World J Gastroenterol; 2019 Apr; 25(13):1550-1559. PubMed ID: 30983815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis-Associated Liver Cancer: Gaps and Opportunities to Improve Care.
    McMahon B; Block J; Block T; Cohen C; Evans AA; Hosangadi A; London WT; Sherman M;
    J Natl Cancer Inst; 2016 Apr; 108(4):. PubMed ID: 26626106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alpha-Fetoprotein Measurement Benefits Hepatocellular Carcinoma Surveillance in Patients with Cirrhosis.
    Chang TS; Wu YC; Tung SY; Wei KL; Hsieh YY; Huang HC; Chen WM; Shen CH; Lu CH; Wu CS; Tsai YH; Huang YH
    Am J Gastroenterol; 2015 Jun; 110(6):836-44; quiz 845. PubMed ID: 25869392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of beta2-microgloblin as a candidate for early diagnosis of imaging-invisible hepatocellular carcinoma in patient with liver cirrhosis.
    Saito Y; Oba N; Nishinakagawa S; Mizuguchi Y; Kojima T; Nomura K; Nakatsura T
    Oncol Rep; 2010 May; 23(5):1325-30. PubMed ID: 20372847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteomic analysis and translational perspective of hepatocellular carcinoma: Identification of diagnostic protein biomarkers by an onco-proteogenomics approach.
    Chiou SH; Lee KT
    Kaohsiung J Med Sci; 2016 Nov; 32(11):535-544. PubMed ID: 27847095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An RNA-based signature enables high specificity detection of circulating tumor cells in hepatocellular carcinoma.
    Kalinich M; Bhan I; Kwan TT; Miyamoto DT; Javaid S; LiCausi JA; Milner JD; Hong X; Goyal L; Sil S; Choz M; Ho U; Kapur R; Muzikansky A; Zhang H; Weitz DA; Sequist LV; Ryan DP; Chung RT; Zhu AX; Isselbacher KJ; Ting DT; Toner M; Maheswaran S; Haber DA
    Proc Natl Acad Sci U S A; 2017 Jan; 114(5):1123-1128. PubMed ID: 28096363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of prothrombin induced by vitamin K absence, macrophage migration inhibitory factor and Golgi protein-73 versus alpha fetoprotein for hepatocellular carcinoma diagnosis and surveillance.
    Ismail MM; Morsi HK; Abdulateef NA; Noaman MK; Abou El-Ella GA
    Scand J Clin Lab Invest; 2017 May; 77(3):175-183. PubMed ID: 28276727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human liver carboxylesterase 1 outperforms alpha-fetoprotein as biomarker to discriminate hepatocellular carcinoma from other liver diseases in Korean patients.
    Na K; Jeong SK; Lee MJ; Cho SY; Kim SA; Lee MJ; Song SY; Kim H; Kim KS; Lee HW; Paik YK
    Int J Cancer; 2013 Jul; 133(2):408-15. PubMed ID: 23319432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The application of proteomics in different aspects of hepatocellular carcinoma research.
    Xing X; Liang D; Huang Y; Zeng Y; Han X; Liu X; Liu J
    J Proteomics; 2016 Aug; 145():70-80. PubMed ID: 27072111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Promoting thorough action for early screening, diagnosis and treatment of liver cancer].
    Fan R; Hou JL
    Zhonghua Gan Zang Bing Za Zhi; 2019 Nov; 27(11):817-821. PubMed ID: 31941233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.